Siggi O. Olafsson
plc Board of Directors effective following the closing of the Warner Chilcott acquisition.
Mr. Olafsson is the President of Actavis Pharma -
generic, branded generic, legacy brands and over-the-counter business.
He joined the Company as Executive Vice President, Global Generics in
, and was appointed President of the Global Generics
business in April 2012.
Prior to joining the Company, Mr. Olafsson served as CEO of the
, Mr. Olafsson held increasingly responsible positions with Pfizer's
Mr. Olafsson has a M.S. in Pharmacy (Cand Pharm) from the